{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:26:48Z","timestamp":1791383208154,"version":"4.3.3"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This article describes the critical role of neurosteroids in postpartum depression (PPD) and outlines the landmark pharmacological journey of brexanolone as a first-in-class neurosteroid antidepressant with significant advantages over traditional antidepressants. PPD is a neuroendocrine disorder that affects about 20% of mothers after childbirth and is characterized by symptoms including persistent sadness, fatigue, dysphoria, as well as disturbances in cognition, emotion, appetite, and sleep. The main pathology behind PPD is the postpartum reduction of neurosteroids, referred to as neurosteroid withdrawal, a concept pioneered by our preclinical studies. We developed neurosteroid replacement therapy (NRT) as a rational approach for treating PPD and other conditions related to neurosteroid deficiency, unveiling the power of neurosteroids as novel anxiolytic-antidepressants. The neurosteroid, brexanolone (BX), is a progesterone-derived allopregnanolone that rapidly relieves anxiety and mood deficits by activating GABA-A receptors, making it a transformational treatment for PPD. In 2019, the FDA approved BX, an intravenous formulation of allopregnanolone, as an NRT to treat PPD. In clinical studies, BX significantly improved PPD symptoms within hours of administration, with tolerable side effects including headache, dizziness, and somnolence. We identified the molecular mechanism of BX in a neuronal PPD-like milieu. The mechanism of BX involves activation of both synaptic and extrasynaptic GABA-A receptors, which promote tonic inhibition and serve as a key target for PPD and related conditions. Neurosteroids offer several advantages over traditional antidepressants, including rapid onset, unique mechanism, and lack of tolerance upon repeated use. Some limitations of BX therapy include lack of aqueous solubility, limited accessibility, hospitalization for treatment, lack of oral product, and serious adverse events at high doses. However, the unmet need for synthetic neurosteroids to address this critical condition supersedes these limitations. Recently, we developed novel hydrophilic neurosteroids with a superior profile and improved drug delivery. Overall, approval of BX is a major milestone in the field of neurotherapeutics, paving the way for the development of novel synthetic neurosteroids to treat depression, epilepsy, and status epilepticus.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s00213-023-06427-2","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T06:01:50Z","timestamp":1691733710000},"page":"1841-1863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy"],"prefix":"10.1007","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-9550","authenticated-orcid":false,"given":"Doodipala Samba","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Mbilinyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"1","key":"6427_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1089\/bfm.2007.9978","volume":"3","author":"ABMPC Academy of Breastfeeding Medicine Protocol Committee","year":"2008","unstructured":"ABMPC Academy of Breastfeeding Medicine Protocol Committee (2008) ABM clinical protocol #18: use of antidepressants in nursing mothers. Breastfeed Med 3(1):44\u201352","journal-title":"Breastfeed Med"},{"issue":"4","key":"6427_CR2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/AOG.0b013e31816fd910","volume":"111","author":"ACOG Committee on Practice Bulletins--Obstetrics","year":"2008","unstructured":"ACOG Committee on Practice Bulletins--Obstetrics (2008) ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 111(4):1001\u20131020","journal-title":"Obstet Gynecol"},{"issue":"10","key":"6427_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.1951.02920280027006","volume":"145","author":"RB Aird","year":"1951","unstructured":"Aird RB, Gordan GS (1951) Anticonvulsive properties of desoxycorticosterone. JAMA 145(10):715\u2013719","journal-title":"JAMA"},{"issue":"Pt 3","key":"6427_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1469-7793.2001.0673e.x","volume":"532","author":"G Akk","year":"2001","unstructured":"Akk G, Bracamontes J, Steinbach JH (2001) Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit. J Physiol 532(Pt 3):673\u2013684","journal-title":"J Physiol"},{"key":"6427_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.physbeh.2018.06.014","volume":"194","author":"FB Almeida","year":"2018","unstructured":"Almeida FB, Fonseca AR, Heidrich N, Nin MS, Barros HMT (2018) The effect of intracerebroventricular allopregnanolone on depressive-like behaviors of rats selectively bred for high and low immobility in the forced swim test. Physiol Behav 194:246\u2013251","journal-title":"Physiol Behav"},{"key":"6427_CR6","doi-asserted-by":"publisher","first-page":"108333","DOI":"10.1016\/j.neuropharm.2020.108333","volume":"181","author":"AL Althaus","year":"2020","unstructured":"Althaus AL, Ackley MA, Belfort GM, Gee SM, Dai J, Nguyen DP, Kazdoba TM, Modgil A, Davies PA, Moss SJ, Salituro FG, Hoffmann E, Hammond RS, Robichaud AJ, Quirk MC, Doherty JJ (2020) Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA-A receptor positive allosteric modulator. Neuropharmacology 181:108333","journal-title":"Neuropharmacology"},{"issue":"7085","key":"6427_CR7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/bmj.314.7085.932","volume":"314","author":"L Appleby","year":"1997","unstructured":"Appleby L, Warner R, Whitton A, Faragher B (1997) A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 314(7085):932\u2013936","journal-title":"BMJ"},{"key":"6427_CR8","doi-asserted-by":"publisher","first-page":"104473","DOI":"10.1016\/j.ebiom.2023.104473","volume":"89","author":"I Balan","year":"2023","unstructured":"Balan I, Patterson R, Boero G, Krohn H, O\u2019Buckley TK, Meltzer-Brody S, Morrow AL (2023) Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathways. EBioMedicine 89:104473","journal-title":"EBioMedicine"},{"issue":"8","key":"6427_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0306-4530(98)00071-7","volume":"23","author":"EE Baulieu","year":"1998","unstructured":"Baulieu EE (1998) Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23(8):963\u2013987","journal-title":"Psychoneuroendocrinology"},{"issue":"19","key":"6427_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.15585\/mmwr.mm6919a2","volume":"69","author":"BL Bauman","year":"2020","unstructured":"Bauman BL, Ko JY, Cox S et al (2020) Vital signs: postpartum depressive symptoms and provider discussions about perinatal depression - United States, 2018. MMWR Morb Mortal Wkly Rep 69(19):575\u2013581","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"6427_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1089\/jwh.2019.7781","volume":"29","author":"HK Betcher","year":"2020","unstructured":"Betcher HK, Wisner KL (2020) Psychotropic treatment during pregnancy: research synthesis and clinical care principles. J Womens Health 29(3):310\u2013318","journal-title":"J Womens Health"},{"issue":"1","key":"6427_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0006-8993(91)90761-J","volume":"561","author":"D Bitran","year":"1991","unstructured":"Bitran D, Hilvers RJ, Kellogg CK (1991) Anxiolytic effects of 3alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABA-A receptor. Brain Res 561(1):157\u2013161","journal-title":"Brain Res"},{"issue":"3","key":"6427_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2826.1995.tb00744.x","volume":"7","author":"D Bitran","year":"1995","unstructured":"Bitran D, Shiekh M, McLeod M (1995) Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABA-A receptors. J Neuroendocrinol 7(3):171\u2013177","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"6427_CR14","first-page":"CD013560","volume":"2","author":"JVE Brown","year":"2021","unstructured":"Brown JVE, Wilson CA, Ayre K, Robertson L, South E, Molyneaux E, Trevillion K, Howard LM, Khalifeh H (2021) Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev 2(2):CD013560","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"6427_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/15622970903144038","volume":"10","author":"R Bunevicius","year":"2009","unstructured":"Bunevicius R, Kusminskas L, Mickuviene N, Bunevicius A, Pedersen CA, Pop VJM (2009) Depressive disorder and thyroid axis functioning during pregnancy. World J Biol Psychiatry 10(4):324\u2013329","journal-title":"World J Biol Psychiatry"},{"key":"6427_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","volume":"230","author":"CM Carver","year":"2013","unstructured":"Carver CM, Reddy DS (2013) Neurosteroid interactions with synaptic and extrasynaptic GABA-A receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology 230:151\u2013188","journal-title":"Psychopharmacology"},{"key":"6427_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1124\/jpet.115.229302","volume":"357","author":"CM Carver","year":"2016","unstructured":"Carver CM, Reddy DS (2016) Neurosteroid structure-activity relationships for functional activation of extrasynaptic \u03b4GABA-A receptors. J Pharmacol Exp Therap 357:188\u2013204","journal-title":"J Pharmacol Exp Therap"},{"key":"6427_CR18","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1523\/JNEUROSCI.3393-15.2016","volume":"36","author":"CM Carver","year":"2016","unstructured":"Carver CM, Chuang S-H, Reddy DS (2016) Zinc selectively blocks neurosteroid-sensitive extrasynaptic \u03b4GABAA receptors in the hippocampus. J Neurosci 36:8070\u20138077","journal-title":"J Neurosci"},{"key":"6427_CR19","doi-asserted-by":"publisher","first-page":"14181","DOI":"10.1523\/JNEUROSCI.0596-14.2014","volume":"34","author":"CM Carver","year":"2014","unstructured":"Carver CM, Wu X, Gangisetty O, Reddy DS (2014) Perimenstrual-like hormonal regulation of extrasynaptic \u03b4-containing GABAA receptors mediating tonic inhibition and neurosteroid sensitivity. J Neurosci 34:14181\u201314197","journal-title":"J Neurosci"},{"key":"6427_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1124\/jpet.117.246660","volume":"365","author":"S-H Chuang","year":"2018","unstructured":"Chuang S-H, Reddy DS (2018) 3\u03b2-Methyl-neurosteroid analogs are preferential positive allosteric modulators and direct activators of extrasynaptic \u03b4-subunit \u03b3-aminobutyric acid type A receptors in the hippocampus dentate gyrus subfield. J Pharmacol Exp Therap 365:583\u2013601","journal-title":"J Pharmacol Exp Therap"},{"key":"6427_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neuropharm.2018.11.031","volume":"148","author":"S-H Chuang","year":"2019","unstructured":"Chuang S-H, Reddy DS (2019) Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus. Neuropharmacology 148:244\u2013256","journal-title":"Neuropharmacology"},{"key":"6427_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1124\/jpet.119.261735","volume":"372","author":"S-H Chuang","year":"2020","unstructured":"Chuang S-H, Reddy DS (2020) Isobolographic analysis of antiseizure activity of the GABA-A receptor-modulating synthetic neurosteroids brexanolone and ganaxolone with tiagabine and midazolam. J Pharmacol Exp Therap 372:285\u2013298","journal-title":"J Pharmacol Exp Therap"},{"key":"6427_CR23","doi-asserted-by":"crossref","unstructured":"Chuang S-H and Reddy, DS (2018a). Genetic and molecular regulation of extrasynaptic GABA-A receptors in the brain: therapeutic insights for epilepsy. J Pharmacol Exp Ther 364, 180-197","DOI":"10.1124\/jpet.117.244673"},{"issue":"2","key":"6427_CR24","doi-asserted-by":"publisher","first-page":"22m14445","DOI":"10.4088\/JCP.22m14445","volume":"84","author":"AH Clayton","year":"2023","unstructured":"Clayton AH, Lasser R, Nandy I, Sankoh AJ, Jonas J, Kanes SJ (2023) Zuranolone in major depressive disorder: results from MOUNTAIN-A phase 3, multicenter, double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 84(2):22m14445","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"6427_CR25","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/jnr.24028","volume":"95","author":"BL Clossen","year":"2017","unstructured":"Clossen BL, Reddy DS (2017) Catamenial-like seizure exacerbation in mice with targeted ablation of extrasynaptic \u03b4GABA-a receptors in the brain. J Neurosci Res 95(10):1906\u20131916","journal-title":"J Neurosci Res"},{"issue":"10","key":"6427_CR26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s40263-019-00672-w","volume":"33","author":"MC Cooper","year":"2019","unstructured":"Cooper MC, Kilvert HS, Hodgkins P, Roskell NS, Eldar-Lissai A (2019) Using matching-adjusted indirect comparisons and network meta-analyses to compare efficacy of brexanolone injection with selective serotonin reuptake inhibitors for treating postpartum depression. CNS Drugs 33(10):1039\u20131052","journal-title":"CNS Drugs"},{"issue":"2","key":"6427_CR27","first-page":"115","volume":"51","author":"EM Cornett","year":"2021","unstructured":"Cornett EM, Rando L, Labb\u00e9 AM, Perkins W, Kaye AM, Kaye AD, Viswanath O, Urits I (2021) Brexanolone to treat postpartum depression in adult women. Psychopharmacol Bull 51(2):115\u2013130","journal-title":"Psychopharmacol Bull"},{"issue":"9","key":"6427_CR28","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.4088\/JCP.15r10174","volume":"77","author":"EQ Cox","year":"2016","unstructured":"Cox EQ, Sowa NA, Meltzer-Brody SE, Gaynes BN (2016) The perinatal depression treatment cascade: baby steps toward improving outcomes. J Clin Psychiatry 77(9):1189\u20131200","journal-title":"J Clin Psychiatry"},{"key":"6427_CR29","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1192\/bjp.150.6.782","volume":"150","author":"JL Cox","year":"1987","unstructured":"Cox JL, Holden JM, Sagovsky R (1987) Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150:782\u2013786","journal-title":"Br J Psychiatry"},{"issue":"2","key":"6427_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0006-8993(86)91500-3","volume":"398","author":"JN Crawley","year":"1986","unstructured":"Crawley JN, Glowa JR, Majewska MD, Paul SM (1986) Anxiolytic activity of an endogenous adrenal steroid. Brain Res 398(2):382\u2013385","journal-title":"Brain Res"},{"key":"6427_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.psyneuen.2016.05.010","volume":"70","author":"KM Deligiannidis","year":"2016","unstructured":"Deligiannidis KM, Kroll-Desrosiers AR, Mo S, Nguyen HP, Svenson A, Jaitly N et al (2016) Peripartum neuroactive steroid and g-aminobutyric acid profiles in women at-risk for postpartum depression. Psychoneuroendocrinology 70:98\u2013107","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"6427_CR32","doi-asserted-by":"publisher","first-page":"e12996","DOI":"10.1111\/jne.12996","volume":"34","author":"S Diviccaro","year":"2022","unstructured":"Diviccaro S, Cioffi L, Falvo E, Giatti S, Melcangi RC (2022) Allopregnanolone: an overview on its synthesis and effects. J Neuroendocrinol 34(2):e12996","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"6427_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.yfrne.2009.05.006","volume":"30","author":"JL Do Rego","year":"2009","unstructured":"Do Rego JL, Seong JY, Burel D et al (2009) Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front Neuroendocrinol 30(3):259\u2013301","journal-title":"Front Neuroendocrinol"},{"issue":"7","key":"6427_CR34","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.pnpbp.2009.07.013","volume":"33","author":"B Doornbos","year":"2009","unstructured":"Doornbos B, Dijck-Brouwer DAJ, Kema IP et al (2009) The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT. Prog Neuropsychopharmacol Biol Psychiatry 33(7):1250\u20131254","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6427_CR35","doi-asserted-by":"publisher","first-page":"699740","DOI":"10.3389\/fpsyt.2021.699740","volume":"12","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Odisho AS, Lewis K, Kaskas A, Hunt G, Cornett EM, Kaye AD, Kaye A, Morgan J, Barrilleaux PS, Lewis D, Viswanath O, Urits I (2021) Brexanolone, a GABAA Modulator, in the treatment of postpartum depression in adults: a comprehensive review. Front Psych 12:699740","journal-title":"Front Psych"},{"issue":"5","key":"6427_CR36","first-page":"627","volume":"26","author":"A Eldar-Lissai","year":"2020","unstructured":"Eldar-Lissai A, Cohen JT, Meltzer-Brody S et al (2020) Cost-effectiveness of brexanolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States. J Manag Care Spec Pharm 26(5):627\u2013638","journal-title":"J Manag Care Spec Pharm"},{"key":"6427_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jad.2022.09.143","volume":"320","author":"CN Epperson","year":"2023","unstructured":"Epperson CN, Rubinow DR, Meltzer-Brody S, Deligiannidis KM, Riesenberg R, Krystal AD, Bankole K, Huang MY, Li H, Brown C, Kanes SJ, Lasser RJ (2023) Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program. Affect Disord 320:353\u2013359","journal-title":"Affect Disord"},{"issue":"8","key":"6427_CR38","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.neuropharm.2012.08.012","volume":"63","author":"J Evans","year":"2012","unstructured":"Evans J, Sun Y, McGregor A, Connor B (2012) Allopregnanolone regulates neurogenesis and depressive\/anxiety-like behavior in a social isolation rodent model of chronic stress. Neuropharmacology 63(8):1315\u20131326","journal-title":"Neuropharmacology"},{"issue":"3","key":"6427_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40263-019-00605-7","volume":"33","author":"A Frieder","year":"2019","unstructured":"Frieder A, Fersh M, Hainline R, Deligiannidis KM (2019) Pharmacotherapy of postpartum depression: current approaches and novel drug development. CNS Drugs 33(3):265\u2013282","journal-title":"CNS Drugs"},{"issue":"3","key":"6427_CR40","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.neuroscience.2010.07.037","volume":"170","author":"O Gangisetty","year":"2010","unstructured":"Gangisetty O, Reddy DS (2010) Neurosteroid withdrawal regulates GABA-A receptor \u03b14-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway. Neuroscience 170(3):865\u2013880","journal-title":"Neuroscience"},{"issue":"6","key":"6427_CR41","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1210\/jcem.83.6.4905","volume":"83","author":"AR Genazzani","year":"1998","unstructured":"Genazzani AR, Petraglia F, Bernardi F et al (1998) Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 83(6):2099\u20132103","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6427_CR42","doi-asserted-by":"publisher","first-page":"26879","DOI":"10.1080\/09513590500361747","volume":"21","author":"S Gilbert Evans","year":"2005","unstructured":"Gilbert Evans S, Ross LE, Sellers EM et al (2005) 3Alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period. Gynecol Endocrinol 21(5):26879","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"6427_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1258\/002367778780953206","volume":"12","author":"CJ Green","year":"1978","unstructured":"Green CJ, Halsey MJ, Precious S, Wardley-Smith B (1978) Alphaxolone-alphadolone anaesthesia in laboratory animals. Lab Anim 12(2):85\u201389","journal-title":"Lab Anim"},{"issue":"2","key":"6427_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13019","volume":"34","author":"H Gunduz-Bruce","year":"2022","unstructured":"Gunduz-Bruce H, Takahashi K, Huang MY (2022) Development of neuroactive steroids for the treatment of postpartum depression. J Neuroendocrinol 34(2):e13019","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"6427_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0028-3908(67)90005-6","volume":"6","author":"L Gyermek","year":"1967","unstructured":"Gyermek L, Genther G, Fleming N (1967) Some effects of progesterone and related steroids on the central nervous system. Int J Neuropharmacol 6(3):191\u2013198","journal-title":"Int J Neuropharmacol"},{"key":"6427_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000358838","volume":"69","author":"C Hellgren","year":"2014","unstructured":"Hellgren C, \u00c5kerud H, Skalkidou A, B\u00e4ckstr\u00f6m T, Sundstr\u00f6m-Poromaa I (2014) Low serum allopregnanolone is associated with symptoms of depression in late pregnancy. Neuropsychobiology 69:147\u2013153","journal-title":"Neuropsychobiology"},{"issue":"1","key":"6427_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.clinthera.2019.11.005","volume":"42","author":"AF Jarman","year":"2020","unstructured":"Jarman AF, MacLean JV, Barron RJ, Wightman RS, McGregor AJ (2020) Brexanolone for postpartum depression: a novel approach and a call for comprehensive postpartum care. Clin Ther 42(1):231\u2013235","journal-title":"Clin Ther"},{"issue":"2","key":"6427_CR48","doi-asserted-by":"publisher","first-page":"e2618","DOI":"10.1002\/hup.2576","volume":"32","author":"SJ Kanes","year":"2017","unstructured":"Kanes SJ, Colquhoun H, Doherty J, Raines S, Hoffmann E, Rubinow DR, Meltzer-Brody S (2017a) Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression. Hum Psychopharmacol 32(2):e2618","journal-title":"Hum Psychopharmacol"},{"issue":"10093","key":"6427_CR49","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","volume":"390","author":"S Kanes","year":"2017","unstructured":"Kanes S, Colquhoun H, Gunduz-Bruce H et al (2017b) Brexanolone (SAGE-547 injection) in post-partum depression: a randomized controlled trial. Lancet 390(10093):480\u2013489","journal-title":"Lancet"},{"issue":"1","key":"6427_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","volume":"67","author":"RT Khisti","year":"2000","unstructured":"Khisti RT, Chopde CT, Jain SP (2000) Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 67(1):137\u2013143","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"6427_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1474-4422(22)00077-1","volume":"21","author":"EMP Knight","year":"2022","unstructured":"Knight EMP, Amin S, Bahi-Buisson N, Benke TA, Cross JH, Demarest ST, Olson HE, Specchio N, Fleming TR, Aimetti AA, Gasior M, Devinsky O, Marigold Trial Group (2022) Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomized, placebo-controlled, phase 3 trial. Lancet Neurol 21(5):417\u2013427","journal-title":"Lancet Neurol"},{"issue":"3","key":"6427_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ogc.2020.05.001","volume":"47","author":"EB Kroska","year":"2020","unstructured":"Kroska EB, Stowe ZN (2020) Postpartum depression: identification and treatment in the clinic setting. Obstet Gynecol Clin North Am 47(3):409\u2013419","journal-title":"Obstet Gynecol Clin North Am"},{"key":"6427_CR53","first-page":"433","volume":"31","author":"SK Kulkarni","year":"1995","unstructured":"Kulkarni SK, Reddy DS (1995) Neurosteroids: a new class of neuromodulators. Drugs of Today 31:433\u2013456","journal-title":"Drugs of Today"},{"issue":"4","key":"6427_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1006\/hbeh.1994.1052","volume":"28","author":"NC Lan","year":"1994","unstructured":"Lan NC, Gee KW (1994) Neuroactive steroid actions at the GABA-A receptor. Horm Behav 28(4):537\u2013544","journal-title":"Horm Behav"},{"issue":"11","key":"6427_CR55","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/phar.2331","volume":"39","author":"LD Leader","year":"2019","unstructured":"Leader LD, O\u2019Connell M, VandenBerg A (2019) Brexanolone for postpartum depression: clinical evidence and practical considerations. Pharmacotherapy 39(11):1105\u20131112","journal-title":"Pharmacotherapy"},{"issue":"19-20","key":"6427_CR56","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1111\/jocn.16121","volume":"31","author":"X Liu","year":"2022","unstructured":"Liu X, Wang S, Wang G (2022) Prevalence and risk factors of postpartum depression in women: a systematic review and meta-analysis. J Clin Nurs 31(19-20):2665\u20132677","journal-title":"J Clin Nurs"},{"key":"6427_CR57","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1002\/jps.22109","volume":"99","author":"DR Luke","year":"2010","unstructured":"Luke DR, Tomaszewski K, Damle B et al (2010) Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD). J Pharm Sci 99:3291\u20133301","journal-title":"J Pharm Sci"},{"issue":"7","key":"6427_CR58","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1210\/jcem.85.7.6675","volume":"85","author":"S Luisi","year":"2000","unstructured":"Luisi S, Petraglia F, Benedetto C et al (2000) Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab 85(7):2429\u20132433","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6427_CR59","first-page":"1912","volume":"81","author":"MA Magiakou","year":"1996","unstructured":"Magiakou MA, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrousos GP (1996) Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab 81(5):1912\u20131917","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6427_CR60","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuron.2008.06.019","volume":"59","author":"J Maguire","year":"2008","unstructured":"Maguire J, Mody I (2008) GABA-AR plasticity during pregnancy: relevance to postpartum depression. Neuron 59(2):207\u2013213","journal-title":"Neuron"},{"issue":"1","key":"6427_CR61","first-page":"23","volume":"32","author":"E Maurer-Spurej","year":"2007","unstructured":"Maurer-Spurej E, Pittendreigh C, Misri S (2007) Platelet serotonin levels support depression scores for women with postpartum depression. J Psychiatry Neurosci 32(1):23\u201329","journal-title":"J Psychiatry Neurosci"},{"key":"6427_CR62","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pneurobio.2013.07.006","volume":"113","author":"RC Melcangi","year":"2014","unstructured":"Melcangi RC et al (2014) Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions. Prog Neurobiol 113:56\u201369","journal-title":"Prog Neurobiol"},{"key":"6427_CR63","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3389\/fendo.2018.00703","volume":"9","author":"L Melon","year":"2018","unstructured":"Melon L, Hammond R, Lewis M, Maguire J (2018) A novel, synthetic, neuroactive steroid is effective at decreasing depression-like behaviors and improving maternal care in preclinical models of postpartum depression. Front Endocrinol 9:703","journal-title":"Front Endocrinol"},{"issue":"1","key":"6427_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.31887\/DCNS.2011.13.1\/smbrody","volume":"13","author":"S Meltzer-Brody","year":"2011","unstructured":"Meltzer-Brody S (2011) New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum. Dialogues Clin Neurosci 13(1):89\u2013100","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"6427_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2018.22","volume":"4","author":"S Meltzer-Brody","year":"2018","unstructured":"Meltzer-Brody S, Howard LM, Bergink V, Vigod S, Jones I, Munk-Olsen T, Honikman S, Milgrom J (2018a) Postpartum psychiatric disorders. Nat Rev Dis Primers 4(1):1\u201318","journal-title":"Nat Rev Dis Primers"},{"issue":"10152","key":"6427_CR66","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","volume":"392","author":"S Meltzer-Brody","year":"2018","unstructured":"Meltzer-Brody S, Colquhoun H, Riesenberg R et al (2018b) Brexanolone injection in post-partum depression: two multicentre, double-blind, randomized, placebo-controlled, phase 3 trials. Lancet 392(10152):1058\u20131070","journal-title":"Lancet"},{"key":"6427_CR67","doi-asserted-by":"publisher","first-page":"100212","DOI":"10.1016\/j.ynstr.2020.100212","volume":"12","author":"S Meltzer-Brody","year":"2020","unstructured":"Meltzer-Brody S, Kanes SJ (2020) Allopregnanolone in postpartum depression: role in pathophysiology and treatment. Neurobiol Stress 12:100212","journal-title":"Neurobiol Stress"},{"key":"6427_CR68","first-page":"CD002018","volume":"9","author":"E Molyneaux","year":"2014","unstructured":"Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K (2014) Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev 9:CD002018","journal-title":"Cochrane Database Syst Rev"},{"key":"6427_CR69","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0006-8993(98)00782-3","volume":"807","author":"MH Moran","year":"1998","unstructured":"Moran MH, Smith S (1998) Progesterone withdrawal. I: proconvulsant effects. Brain Res 807:84\u201390","journal-title":"Brain Res"},{"issue":"1","key":"6427_CR70","first-page":"77","volume":"97","author":"RE Nappi","year":"2001","unstructured":"Nappi RE, Petraglia F, Luisi S, Polatti F, Farina C, Genazzani AR (2001) Serum allopregnanolone in women with postpartum \u201cblues\u201d. Obstet Gynecol 97(1):77\u201380","journal-title":"Obstet Gynecol"},{"key":"6427_CR71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neuron.2008.07.015","volume":"59","author":"CB Nemeroff","year":"2008","unstructured":"Nemeroff CB (2008) Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Neuron 59:185\u2013186","journal-title":"Neuron"},{"issue":"3","key":"6427_CR72","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/GRF.0000000000000353","volume":"61","author":"MW O\u2019Hara","year":"2018","unstructured":"O\u2019Hara MW, Engeldinger J (2018) Treatment of postpartum depression: recommendations for the clinician. Clin Obstet Gynecol 61(3):604\u2013614","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"6427_CR73","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1750-3639.2002.tb00467.x","volume":"12","author":"JW Olney","year":"2002","unstructured":"Olney JW, Wozniak DF, Jevtovic-Todorovic V, Farber NB, Bittigau P, Ikonomidou C (2002) Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol Zurich Switz 12(4):488\u2013498","journal-title":"Brain Pathol Zurich Switz"},{"issue":"3","key":"6427_CR74","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ogc.2018.04.005","volume":"45","author":"LM Osborne","year":"2018","unstructured":"Osborne LM (2018) Recognizing and managing postpartum psychosis: a clinical guide for obstetric providers. Obstet Gynecol Clin North Am 45(3):455\u2013468","journal-title":"Obstet Gynecol Clin North Am"},{"key":"6427_CR75","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.psyneuen.2017.02.012","volume":"79","author":"LM Osborne","year":"2017","unstructured":"Osborne LM, Gispen F, Sanyal A, Yenokyan G, Meilman S, Payne JL (2017) Lower allopregnanolone during pregnancy predicts postpartum depression: an exploratory study. Psychoneuroendocrinology 79:116\u2013121","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"6427_CR76","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.psyneuen.2005.11.006","volume":"31","author":"AM Paoletti","year":"2006","unstructured":"Paoletti AM, Romagnino S, Contu R et al (2006) Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. Psychoneuroendocrinology 31(4):485\u2013492","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"6427_CR77","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1210\/jc.2004-0444","volume":"90","author":"A Parizek","year":"2005","unstructured":"Parizek A, Hill M, Kancheva R et al (2005) Neuroactive pregnanolone isomers during pregnancy. J Clin Endocrinol Metab 90(1):395\u2013403","journal-title":"J Clin Endocrinol Metab"},{"key":"6427_CR78","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.yfrne.2018.12.001","volume":"52","author":"JL Payne","year":"2019","unstructured":"Payne JL, Maguire J (2019) Pathophysiological mechanisms implicated in postpartum depression. Front Neuroendocrinol 52:165\u2013180","journal-title":"Front Neuroendocrinol"},{"issue":"4","key":"6427_CR79","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ajog.2008.11.033","volume":"200","author":"T Pearlstein","year":"2009","unstructured":"Pearlstein T, Howard M, Salisbury A, Zlotnick C (2009) Postpartum depression. Am J Obstet Gynecol 200(4):357\u2013364","journal-title":"Am J Obstet Gynecol"},{"key":"6427_CR80","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.steroids.2014.12.007","volume":"95","author":"KD Pennell","year":"2015","unstructured":"Pennell KD, Woodin MA, Pennell PB (2015) Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry. Steroids 95:24\u201331","journal-title":"Steroids"},{"issue":"4","key":"6427_CR81","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1073\/pnas.0337642100","volume":"100","author":"G Pinna","year":"2003","unstructured":"Pinna G, Dong E, Matsumoto K, Costa E, Guidotti A (2003) In socially isolated mice, the reversal of brain allopregnanolone downregulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci U S A 100(4):2035\u20132040","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6427_CR82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/01612840701748698","volume":"29","author":"MD Pinto-Foltz","year":"2008","unstructured":"Pinto-Foltz MD, Logsdon MC (2008) Stigma towards mental illness: a concept analysis using postpartum depression as an exemplar. Issues Ment Health Nurs 29(1):21\u201336","journal-title":"Issues Ment Health Nurs"},{"key":"6427_CR83","doi-asserted-by":"publisher","unstructured":"Pluchino N, Ansaldi Y, Genazzani AR (2019) Brain intracrinology of allopregnanolone during pregnancy and hormonal contraception. Horm Mol Biol Clin Invest 37(1). https:\/\/doi.org\/10.1515\/hmbci-2018-0032","DOI":"10.1515\/hmbci-2018-0032"},{"issue":"1","key":"6427_CR84","first-page":"29","volume":"27","author":"N Pluchino","year":"2016","unstructured":"Pluchino N, Russo M, Genazzani AR (2016) The fetal brain: role of progesterone and allopregnanolone. Horm Mol Biol Clin Invest 27(1):29\u201334X","journal-title":"Horm Mol Biol Clin Invest"},{"key":"6427_CR85","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fendo.2019.00169","volume":"10","author":"MH Ratner","year":"2019","unstructured":"Ratner MH, Kumaresan V, Farb DH (2019) Neurosteroid actions in memory and neurologic\/ neuropsychiatric disorders. Front Endocrinol 10:169","journal-title":"Front Endocrinol"},{"issue":"3-4","key":"6427_CR86","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1615\/CritRevNeurobiol.v15.i34.20","volume":"15","author":"DS Reddy","year":"2003","unstructured":"Reddy DS (2003a) Pharmacology of endogenous neuroactive steroids. Crit Rev Neurobiol 15(3-4):197\u2013234","journal-title":"Crit Rev Neurobiol"},{"issue":"3","key":"6427_CR87","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0165-6147(03)00023-3","volume":"24","author":"DS Reddy","year":"2003","unstructured":"Reddy DS (2003b) Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol Sci 24(3):103\u2013106","journal-title":"Trends Pharmacol Sci"},{"key":"6427_CR88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.eplepsyres.2004.09.003","volume":"62","author":"DS Reddy","year":"2004","unstructured":"Reddy DS (2004) Role of neurosteroids in catamenial epilepsy. Epilepsy Res 62:99\u2013118","journal-title":"Epilepsy Res"},{"key":"6427_CR89","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.neuint.2007.05.019","volume":"52","author":"DS Reddy","year":"2008","unstructured":"Reddy DS (2008) Mass spectrometric assay and physiological\u2013pharmacological activity of androgenic neurosteroids. Neurochem Int 52:541\u2013553","journal-title":"Neurochem Int"},{"issue":"1","key":"6427_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2009.02.017","volume":"85","author":"DS Reddy","year":"2009","unstructured":"Reddy DS (2009) The role of neurosteroids in pathophysiology and treatment of catamenial epilepsy. Epilepsy Res 85(1):1\u201330","journal-title":"Epilepsy Res"},{"key":"6427_CR91","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","volume":"186","author":"DS Reddy","year":"2010","unstructured":"Reddy DS (2010) Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186:113\u2013137","journal-title":"Prog Brain Res"},{"key":"6427_CR92","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fendo.2011.00038","volume":"2","author":"DS Reddy","year":"2011","unstructured":"Reddy DS (2011) Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy. Front Endocrinol 2:38","journal-title":"Front Endocrinol"},{"key":"6427_CR93","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.yhbeh.2012.04.016","volume":"63","author":"DS Reddy","year":"2013","unstructured":"Reddy DS (2013a) Neuroendocrine aspects of catamenial epilepsy. Horm Behav 63:254\u2013266","journal-title":"Horm Behav"},{"key":"6427_CR94","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fncel.2013.00115","volume":"7","author":"DS Reddy","year":"2013","unstructured":"Reddy DS (2013b) Role of hormones and neurosteroids in epileptogenesis. Front Cell Neurosci 7:115","journal-title":"Front Cell Neurosci"},{"key":"6427_CR95","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.nbd.2014.06.010","volume":"72","author":"DS Reddy","year":"2014","unstructured":"Reddy DS (2014) Neurosteroids and their role in sex-specific epilepsies. Neurobiol Dis 72:198\u2013209","journal-title":"Neurobiol Dis"},{"key":"6427_CR96","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fncel.2016.00101","volume":"10","author":"DS Reddy","year":"2016","unstructured":"Reddy DS (2016) Catamenial epilepsy: discovery of an extrasynaptic molecular mechanism for targeted therapy. Front Cell Neurosci 10:101","journal-title":"Front Cell Neurosci"},{"key":"6427_CR97","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/bs.vh.2017.12.001","volume":"107","author":"DS Reddy","year":"2018","unstructured":"Reddy DS (2018) GABA-A receptors mediate tonic inhibition and neurosteroid sensitivity in the brain. Vitam Horm 107:177\u2013191","journal-title":"Vitam Horm"},{"key":"6427_CR98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cotox.2019.08.001","volume":"14","author":"DS Reddy","year":"2019","unstructured":"Reddy DS (2019) Mechanism-based novel antidotes for organophosphate neurotoxicity. Curr Opin Toxicol 14:35\u201345","journal-title":"Curr Opin Toxicol"},{"issue":"2","key":"6427_CR99","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/jne.13028","volume":"34","author":"DS Reddy","year":"2022","unstructured":"Reddy DS (2022) Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women. J Neuroendocrinol 34(2):e13028","journal-title":"J Neuroendocrinol"},{"key":"6427_CR100","doi-asserted-by":"crossref","unstructured":"Reddy DS (2023) Neuroendocrine insights of neurosteroid therapy for postpartum depression. Trends Mol Med","DOI":"10.1016\/j.molmed.2023.07.006"},{"key":"6427_CR101","doi-asserted-by":"crossref","unstructured":"Reddy DS, Bakshi K (2020) Neurosteroids: biosynthesis, molecular mechanisms, and neurophysiological functions in the human brain. In: Litwack G (ed) Hormonal signaling in biology and medicine. Academic Press, pp 69-82.","DOI":"10.1016\/B978-0-12-813814-4.00004-3"},{"key":"6427_CR102","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1124\/jpet.110.169854","volume":"334","author":"DS Reddy","year":"2010","unstructured":"Reddy DS, Jian K (2010) The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors. J Pharmacol Exp Therap 334:1031\u20131041","journal-title":"J Pharmacol Exp Therap"},{"key":"6427_CR103","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0079-6468(08)70059-6","volume":"37","author":"DS Reddy","year":"2000","unstructured":"Reddy DS, Kulkarni SK (2000) Development of neurosteroid-based novel psychotropic drugs. Prog Med Chem 37:135\u2013176","journal-title":"Prog Med Chem"},{"key":"6427_CR104","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1523\/JNEUROSCI.4488-10.2011","volume":"31","author":"DS Reddy","year":"2011","unstructured":"Reddy DS, Mohan A (2011) Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors. J Neurosci 31:650\u2013658","journal-title":"J Neurosci"},{"key":"6427_CR105","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.yebeh.2012.05.024","volume":"25","author":"DS Reddy","year":"2012","unstructured":"Reddy DS, Ramanathan G (2012) Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis. Epilepsy Behav 25:92\u201397","journal-title":"Epilepsy Behav"},{"issue":"1","key":"6427_CR106","first-page":"1","volume":"295","author":"DS Reddy","year":"2000","unstructured":"Reddy DS, Rogawski MA (2000a) Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J Pharmacol Exp Therap 295(1):1\u20138","journal-title":"J Pharmacol Exp Therap"},{"issue":"3","key":"6427_CR107","first-page":"909","volume":"294","author":"DS Reddy","year":"2000","unstructured":"Reddy DS, Rogawski MA (2000b) Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy. J Pharmacol Exp Therap 294(3):909\u2013915","journal-title":"J Pharmacol Exp Therap"},{"key":"6427_CR108","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1528-1157.2001.10200.x","volume":"42","author":"DS Reddy","year":"2001","unstructured":"Reddy DS, Rogawski MA (2001) Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 42:337\u2013344","journal-title":"Epilepsia"},{"issue":"9","key":"6427_CR109","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1523\/JNEUROSCI.22-09-03795.2002","volume":"22","author":"DS Reddy","year":"2002","unstructured":"Reddy DS, Rogawski MA (2002) Stress-induced deoxycorticosterone-derived neurosteroids modulate GABAA receptor function and seizure susceptibility. J Neurosci 22(9):3795\u20133805","journal-title":"J Neurosci"},{"issue":"2\u20133","key":"6427_CR110","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.eplepsyres.2010.01.009","volume":"89","author":"DS Reddy","year":"2010","unstructured":"Reddy DS, Rogawski MA (2010) Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res 89(2\u20133):254\u2013260","journal-title":"Epilepsy Res"},{"key":"6427_CR111","volume-title":"Jasper\u2019s basic mechanisms of the epilepsies [Internet],&nbsp;&nbsp;pp-982-1000.&nbsp;","author":"DS Reddy","year":"2012","unstructured":"Reddy DS, Rogawski MA (2012) Neurosteroids \u2014 endogenous regulators of seizure susceptibility and role in the treatment of epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) Jasper\u2019s basic mechanisms of the epilepsies [Internet], 4th edn. NCBI, Bethesda (MD)","edition":"4"},{"key":"6427_CR112","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1358\/dof.2004.029.03.793135","volume":"29","author":"DS Reddy","year":"2004","unstructured":"Reddy DS, Woodward R (2004) Ganaxolone: a prospective overview. Drugs Future 29:227\u2013242","journal-title":"Drugs Future"},{"issue":"7","key":"6427_CR113","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.tips.2016.04.003","volume":"37","author":"DS Reddy","year":"2016","unstructured":"Reddy DS, Estes WA (2016) Clinical potential of neurosteroids for CNS disorders. Trends Pharmacol Sci 37(7):543\u2013561","journal-title":"Trends Pharmacol Sci"},{"key":"6427_CR114","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/epi.14693","volume":"60","author":"DS Reddy","year":"2019","unstructured":"Reddy DS, Carver CM, Clossen B, Wu X (2019) Extrasynaptic GABA-A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures. Epilepsia 60:730\u2013743","journal-title":"Epilepsia"},{"key":"6427_CR115","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/jpet.104.065268","volume":"310","author":"DS Reddy","year":"2004","unstructured":"Reddy DS, Castaneda DC, O'Malley BW, Rogawski MA (2004) Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther 310:230\u2013239","journal-title":"J Pharmacol Exp Ther"},{"key":"6427_CR116","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.neuropharm.2010.08.017","volume":"59","author":"DS Reddy","year":"2010","unstructured":"Reddy DS, Gangisetty O, Briyal S (2010) Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis. Neuropharmacology 59:573\u2013581","journal-title":"Neuropharmacology"},{"key":"6427_CR117","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.brainres.2017.01.030","volume":"1659","author":"DS Reddy","year":"2017","unstructured":"Reddy DS, Gangisetty O, Wu X (2017) PR-independent neurosteroid regulation of \u03b12-GABA-A receptors in the hippocampus subfields. Brain Res 1659:142\u2013147","journal-title":"Brain Res"},{"key":"6427_CR118","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1124\/jpet.112.192377","volume":"341","author":"DS Reddy","year":"2012","unstructured":"Reddy DS, Gould J, Gangisetty O (2012) A mouse kindling model of perimenstrual catamenial epilepsy. J Pharmacol Exp Therap 341:784\u2013793","journal-title":"J Pharmacol Exp Therap"},{"issue":"13","key":"6427_CR119","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1097\/00001756-199809140-00028","volume":"9","author":"DS Reddy","year":"1998","unstructured":"Reddy DS, Kaur G, Kulkarni SK (1998) Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neuroreport 9(13):3069\u20133073","journal-title":"Neuroreport"},{"issue":"3","key":"6427_CR120","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1046\/j.1528-1157.2001.10100.x","volume":"42","author":"DS Reddy","year":"2001","unstructured":"Reddy DS, Kim HY, Rogawski MA (2001) Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 42(3):328\u2013336","journal-title":"Epilepsia"},{"issue":"3","key":"6427_CR121","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s002130050136","volume":"128","author":"DS Reddy","year":"1996","unstructured":"Reddy DS, Kulkarni SK (1996) Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology 128(3):280\u2013292","journal-title":"Psychopharmacology"},{"issue":"1-2","key":"6427_CR122","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0006-8993(96)01447-3","volume":"752","author":"DS Reddy","year":"1997","unstructured":"Reddy DS, Kulkarni SK (1997a) Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res 752(1-2):61\u201371","journal-title":"Brain Res"},{"issue":"10","key":"6427_CR123","first-page":"665","volume":"19","author":"DS Reddy","year":"1997","unstructured":"Reddy DS, Kulkarni SK (1997b) Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice. Methods Find Exp Clin Pharmacol 19(10):665\u2013681","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"6","key":"6427_CR124","first-page":"395","volume":"19","author":"DS Reddy","year":"1997","unstructured":"Reddy DS, Kulkarni SK (1997c) Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice. Methods Find Exp Clin Pharmacol 19(6):395\u2013405","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"4","key":"6427_CR125","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s002130050635","volume":"137","author":"DS Reddy","year":"1998","unstructured":"Reddy DS, Kulkarni SK (1998) The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology 137(4):391\u2013400","journal-title":"Psychopharmacology"},{"issue":"1","key":"6427_CR126","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0091-3057(98)00126-9","volume":"62","author":"DS Reddy","year":"1999","unstructured":"Reddy DS, Kulkarni SK (1999) Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats. Pharmacol Biochem Behav 62(1):53\u201360","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"6427_CR127","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuropharm.2004.09.002","volume":"48","author":"DS Reddy","year":"2005","unstructured":"Reddy DS, O\u2019Malley BW, Rogawski MA (2005) Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 48(1):14\u201324","journal-title":"Neuropharmacology"},{"issue":"1","key":"6427_CR128","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2004.11.026","volume":"1033","author":"DS Reddy","year":"2005","unstructured":"Reddy DS, Apanites LA (2005) Anesthetic effects of progesterone are undiminished in progesterone receptor knockout mice. Brain Res 1033(1):96\u2013101","journal-title":"Brain Res"},{"issue":"10","key":"6427_CR129","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1358\/mf.2007.29.10.1147766","volume":"29","author":"DS Reddy","year":"2007","unstructured":"Reddy DS, Zeng YC (2007) Differential anesthetic activity of ketamine and the GABAergic neurosteroid allopregnanolone in mice lacking progesterone receptor A and B subtypes. Methods Find Exp Clin Pharmacol 29(10):659\u2013664","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"2","key":"6427_CR130","first-page":"392","volume":"6","author":"DS Reddy","year":"2009","unstructured":"Reddy DS, Rogawski MA (2009) Neurosteroid replacement therapy for catamenial epilepsy. Neurother J Am Soc Exp Neurother 6(2):392\u2013401","journal-title":"Neurother J Am Soc Exp Neurother"},{"issue":"3","key":"6427_CR131","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1124\/jpet.114.222075","volume":"353","author":"SD Reddy","year":"2015","unstructured":"Reddy SD, Younus I, Clossen BL, Reddy DS (2015) Antiseizure activity of midazolam in mice lacking \u03b4-subunit extrasynaptic GABA-A receptors. J Pharmacol Exp Ther 353(3):517\u2013528","journal-title":"J Pharmacol Exp Ther"},{"key":"6427_CR132","doi-asserted-by":"publisher","first-page":"135753","DOI":"10.1016\/j.neulet.2021.135753","volume":"750","author":"DS Reddy","year":"2021","unstructured":"Reddy DS, Thompson W, Calderara G (2021) Molecular mechanisms of sex differences in epilepsy and seizure susceptibility in chemical, genetic and acquired epileptogenesis. Neurosci Lett 750:135753","journal-title":"Neurosci Lett"},{"key":"6427_CR133","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/7854_2020_191","volume":"55","author":"DS Reddy","year":"2022","unstructured":"Reddy DS, Thompson W, Calderara G (2022) Does stress trigger seizures? Evidence from experimental models. Curr Top Behav Neurosci 55:41\u201364","journal-title":"Curr Top Behav Neurosci"},{"issue":"1-6","key":"6427_CR134","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0960-0760(95)00233-2","volume":"56","author":"R Rupprecht","year":"1996","unstructured":"Rupprecht R, Hauser CA, Trapp T, Holsboer F (1996) Neurosteroids: molecular mechanisms of action and psychopharmacological significance. J Steroid Biochem Mol Biol 56(1-6):163\u2013168","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"6427_CR135","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0166-2236(99)01399-5","volume":"22","author":"R Rupprecht","year":"1999","unstructured":"Rupprecht R, Holsboer F (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22(9):410\u2013416","journal-title":"Trends Neurosci"},{"issue":"12","key":"6427_CR136","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G et al (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9(12):971\u2013988","journal-title":"Nat Rev Drug Discov"},{"key":"6427_CR137","unstructured":"Tolliday SL (2021) Moms are not ok: understand, recognize, and treat postpartum depression. Pharm Times 87(10)"},{"issue":"2","key":"6427_CR138","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/ijgo.14129","volume":"157","author":"M Safi-Keykaleh","year":"2022","unstructured":"Safi-Keykaleh M, Aliakbari F, Safarpour H, Safari M, Tahernejad A, Sheikhbardsiri H, Sahebi A (2022) Prevalence of postpartum depression in women amid the COVID-19 pandemic: a systematic review and meta-analysis. Int J Gynaecol Obstet 157(2):240\u2013247","journal-title":"Int J Gynaecol Obstet"},{"key":"6427_CR139","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1017\/S1092852914000480","volume":"20","author":"C Schiller","year":"2014","unstructured":"Schiller C, Meltzer-Brody S, Rubinow D (2014) The role of reproductive hormones in postpartum depression. CNS Spectr 20:48\u201359","journal-title":"CNS Spectr"},{"issue":"1","key":"6427_CR140","first-page":"68","volume":"84","author":"A \u0160ebela","year":"2019","unstructured":"\u0160ebela A, Hanka J, Mohr P (2019) Diagnostics and modern trends in therapy of postpartum depression. Ceska Gynekol 84(1):68\u201372","journal-title":"Ceska Gynekol"},{"issue":"2430","key":"6427_CR141","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.94.2430.94","volume":"94","author":"H Selye","year":"1941","unstructured":"Selye H (1941) On the hormonal activity of a steroid compound. Science 94(2430):94","journal-title":"Science"},{"issue":"43","key":"6427_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14430","volume":"14","author":"D Sharp","year":"2010","unstructured":"Sharp D, Chew-Graham C, Tylee A, Lewis G, Howard L, Anderson I (2010) A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: theRESPOND trial. Health Technol Assess 14(43):1\u2013153","journal-title":"Health Technol Assess"},{"key":"6427_CR143","doi-asserted-by":"publisher","first-page":"112670","DOI":"10.1016\/j.bbr.2020.112670","volume":"390","author":"Y Shirayama","year":"2020","unstructured":"Shirayama Y, Fujita Y, Oda Y, Iwata M, Muneoka K, Hashimoto K (2020) Allopregnanolone induces antidepressant-like effects through BDNF-TrkB signaling independent from AMPA receptor activation in a rat learned helplessness model of depression. Behav Brain Res 390:112670","journal-title":"Behav Brain Res"},{"issue":"392","key":"6427_CR144","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/31948","volume":"1998","author":"SS Smith","year":"1998","unstructured":"Smith SS, Gong QH, Hsu F-C, Markowitz RS, Li X (1998) GABA-A receptor \u03b14 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 1998(392):926\u2013929","journal-title":"Nature."},{"issue":"5","key":"6427_CR145","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00737-021-01175-8","volume":"24","author":"M Spinelli","year":"2021","unstructured":"Spinelli M (2021) Postpartum psychosis: a diagnosis for the DSMV. Arch Womens Ment Health 24(5):817\u2013822","journal-title":"Arch Womens Ment Health"},{"issue":"6","key":"6427_CR146","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1089\/bfm.2015.29002","volume":"10","author":"NK Sriraman","year":"2015","unstructured":"Sriraman NK, Melvin K, Meltzer-Brody S (2015) ABM Clinical Protocol #18: use of antidepressants in breastfeeding mothers. Breastfeed Med 10(6):290\u2013299","journal-title":"Breastfeed Med"},{"issue":"22","key":"6427_CR147","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1056\/NEJMcp1607649","volume":"375","author":"DE Stewart","year":"2016","unstructured":"Stewart DE, Vigod S (2016) Postpartum depression. N Engl J Med 375(22):2177\u20132186","journal-title":"N Engl J Med"},{"key":"6427_CR148","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1146\/annurev-med-041217-011106","volume":"70","author":"DE Stewart","year":"2019","unstructured":"Stewart DE, Vigod SN (2019) Postpartum depression: pathophysiology, treatment, and emerging therapeutics. Annu Rev Med 70:183\u2013196","journal-title":"Annu Rev Med"},{"issue":"4","key":"6427_CR149","doi-asserted-by":"publisher","first-page":"e000616","DOI":"10.1136\/bmjoq-2018-000616","volume":"8","author":"S Sudhanthar","year":"2019","unstructured":"Sudhanthar S, Sheikh ZEH, Thakur K (2019) Postpartum depression screening: are we doing a competent job? BMJ Open Qual 8(4):e000616","journal-title":"BMJ Open Qual"},{"issue":"5","key":"6427_CR150","doi-asserted-by":"publisher","first-page":"e22473","DOI":"10.1002\/jbt.22473","volume":"34","author":"N Tian","year":"2020","unstructured":"Tian N, Liang H, Luo W et al (2020) GABA consumption during early pregnancy impairs endometrial receptivity and embryo development in mice. J Biochem Mol Toxicol 34(5):e22473","journal-title":"J Biochem Mol Toxicol"},{"key":"6427_CR151","doi-asserted-by":"publisher","first-page":"215013272110593","DOI":"10.1177\/21501327211059348","volume":"12","author":"S Usmani","year":"2021","unstructured":"Usmani S, Greca E, Javed S, Sharath M, Sarfraz Z, Sarfraz A, Salari SW, Hussaini SS, Mohammadi A, Chellapuram N, Cabrera E, Ferrer G (2021) Risk factors for postpartum depression during COVID-19 pandemic: a systematic literature review. J Prim Care Community Health 12:21501327211059348","journal-title":"J Prim Care Community Health"},{"issue":"22","key":"6427_CR152","doi-asserted-by":"publisher","first-page":"12599","DOI":"10.1073\/pnas.93.22.12599","volume":"93","author":"DP Uzunova","year":"1996","unstructured":"Uzunova DP, Cooper TB, Costa E, Guidotti A (1996) Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci U S A 93(22):12599\u201312604","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6427_CR153","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","volume":"95","author":"V Uzunova","year":"1998","unstructured":"Uzunova V, Sheline Y, Davis JM et al (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95(6):3239\u20133244","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"6427_CR154","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s40262-022-01155-w","volume":"61","author":"J Wald","year":"2022","unstructured":"Wald J, Henningsson A, Hanze E, Hoffmann E, Li H, Colquhoun H, Deligiannidis KM (2022) Allopregnanolone concentrations in breast milk and plasma from healthy volunteers receiving brexanolone injection, with population pharmacokinetic modeling of potential relative infant dose. Clin Pharmacokinet 61(9):1307\u20131319","journal-title":"Clin Pharmacokinet"},{"key":"6427_CR155","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1016\/j.jval.2020.04.904","volume":"23","author":"M Vatturi","year":"2020","unstructured":"Vatturi M, Dovari A, Inuganti B (2020) Efficacy and safety of brexanolone in the treatment of postpartum depression: a systematic review and meta-analysis. Value Health 23:S260","journal-title":"Value Health"},{"issue":"6","key":"6427_CR156","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1176\/appi.ajp.161.6.1066","volume":"161","author":"AM Weissman","year":"2004","unstructured":"Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, Wisner KL (2004) Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 161(6):1066\u20131078","journal-title":"Am J Psychiatry"},{"issue":"4","key":"6427_CR157","doi-asserted-by":"publisher","first-page":"903-914. 9","DOI":"10.1007\/s10995-016-2192-9","volume":"21","author":"A Wilkinson","year":"2017","unstructured":"Wilkinson A, Anderson S, Wheeler SB (2017) Screening for and treating postpartum depression and psychosis: a cost-effectiveness analysis. Matern Child Health J 21(4):903-914. 9","journal-title":"Matern Child Health J"},{"key":"6427_CR158","doi-asserted-by":"publisher","first-page":"100198","DOI":"10.1016\/j.ynstr.2019.100198","volume":"11","author":"N Walton","year":"2019","unstructured":"Walton N, Maguire J (2019) Allopregnanolone-based treatments for postpartum depression: why\/how do they work? Neurobiol Stress 11:100198","journal-title":"Neurobiol Stress"},{"key":"6427_CR159","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1124\/jpet.113.203653","volume":"346","author":"X Wu","year":"2013","unstructured":"Wu X, Gangisetty O, Carver CM, Reddy DS (2013) Estrous cycle regulation of extrasynaptic \u03b4-containing GABA-A receptor-mediated tonic inhibition and limbic epileptogenesis. J Pharmacol Exp Therap 346:146\u2013160","journal-title":"J Pharmacol Exp Therap"},{"issue":"11","key":"6427_CR160","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1176\/appi.ajp.158.11.1856","volume":"158","author":"KA Yonkers","year":"2001","unstructured":"Yonkers KA, Ramin SM, Rush AJ et al (2001) Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am J Psychiatry 158(11):1856\u20131863","journal-title":"Am J Psychiatry"},{"key":"6427_CR161","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/17512433.2018.1386553","volume":"11","author":"I Younus","year":"2018","unstructured":"Younus I, Reddy DS (2018) A resurging boom in new drugs for epilepsy and brain disorders. Expert Rev Clin Pharmacol 11:27\u201345","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6427_CR162","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.psychres.2019.07.006","volume":"279","author":"W Zheng","year":"2019","unstructured":"Zheng W, Cai DB, Zheng W et al (2019) Brexanolone for postpartum depression: a meta-analysis of randomized controlled studies. Psychiatry Res 279:83\u201389","journal-title":"Psychiatry Res"},{"key":"6427_CR163","doi-asserted-by":"publisher","first-page":"102353","DOI":"10.1016\/j.ajp.2020.102353","volume":"53","author":"XH Zhao","year":"2020","unstructured":"Zhao XH, Zhang ZH (2020) Risk factors for postpartum depression: an evidence-based systematic review of systematic reviews and meta-analyses. Asian J Psychiatr 53:102353","journal-title":"Asian J Psychiatr"},{"key":"6427_CR164","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ynstr.2019.100196","volume":"11","author":"CF Zorumski","year":"2019","unstructured":"Zorumski CF, Paul SM, Covey DF, Mennerick S (2019) Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond. Neurobiology Stress 11:10","journal-title":"Neurobiology Stress"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-023-06427-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T06:02:27Z","timestamp":1693461747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-023-06427-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":164,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6427"],"URL":"https:\/\/doi.org\/10.1007\/s00213-023-06427-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"23 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The content is the sole responsibility of the authors and does not necessarily represent official views of the National Institutes of Health, the Department of Defense, or Texas A&M University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}